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Protein misfoldingA speciﬁc neuronal vulnerability to amyloid protein toxicity may account for brain susceptibility to protein
misfolding diseases. To investigate this issue, we compared the effects induced by oligomers from salmon
calcitonin (sCTOs), a neurotoxic amyloid protein, on cells of different histogenesis: mature and immature
primary hippocampal neurons, primary astrocytes, MG63 osteoblasts and NIH-3T3 ﬁbroblasts. In mature
neurons, sCTOs increased apoptosis and induced neuritic and synaptic damages similar to those caused by
amyloid β oligomers. Immature neurons and the other cell types showed no cytotoxicity. sCTOs caused
cytosolic Ca2+ rise in mature, but not in immature neurons and the other cell types. Comparison of plasma
membrane lipid composition showed that mature neurons had the highest content in lipid rafts, suggesting a
key role for them in neuronal vulnerability to sCTOs. Consistently, depletion in gangliosides protected against
sCTO toxicity. We hypothesize that the high content in lipid rafts makes mature neurons especially
vulnerable to amyloid proteins, as compared to other cell types; this may help explain why the brain is a
target organ for amyloid-related diseases.+39 06 49387140.
i-Albedi).
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A number of degenerative disorders are pathogenetically linked to
a process of misfolding and aggregation of speciﬁc proteins, the large
family of the so-called amyloid proteins [1–3].The process of aggre-
gation that leads to the characteristic cytotoxic properties generally
proceeds through the formation of dimers, oligomers and protoﬁbrils,
before ﬁnally assuming an insoluble ﬁbrillar conformation, charac-
terized by β-structures. It is now generally agreed that the cytotoxic
species are the soluble, oligomeric aggregates, while the insoluble
ﬁbrils seem to be relatively non-harmful. Small oligomeric assemblies
of Amyloid β (Aβ) for example have been speciﬁcally shown to impair
long-term potentiation and dendritic spine structure in the hippo-
campus and to disrupt cognition in animals (For a review see
Nimmrich and Ebert, 2009 [4]). Several ﬁndings suggest that a
common pathologic pathway exists in the case of amyloid associated
neurodegenerative diseases, which is independent from the peptide
primary sequence [5,6]. According to this hypothesis, neurotoxicity of
extracellular amyloid aggregates is due to the formation of Ca2+-permeable channels by incorporation of amyloid protein oligomers in
the plasma membrane, resulting in an imbalance in Ca2+ inﬂow and
consequent cell death [5,7–9].
Calcitonin is a polypeptidic hormone secreted by the thyroid gland
and, due to its typical aggregation behavior, belongs to the amyloid
family [10,11]. Even if it is not involved in any neurodegenerative
diseases, aggregated CT is toxic to neurons in vitro [12–15], like other
amyloid proteins.
Salmon Calcitonin (sCT), found to be neurotoxic as CT from other
species [12,13,16], is characterized by a slower aggregation rate [16]
and this peculiarity is at the basis of its pharmacological use. This
observation may provoke concern, since the possibility that protein
aggregates may reach the brain from the blood circulation and trigger
a neurotoxic reaction should be taken into consideration, especially
considering CT is often delivered as a nasal spray [17]. We have
recently shown that sCT Oligomers (sCTOs) form Ca2+-permeable
pores in liposomes [18], highly reminiscent of the ion channels
formed by other amyloid proteins, such as Aβ and α synuclein
[6,9,19,20]. We have also shown that sCTO insertion in model
membranes occurs only in the presence of GM1 ganglioside and
cholesterol, which are typical components of lipid rafts [21]. A large
body of evidence sustains a role for lipid rafts in amyloid-induced
neurotoxicity. Lipid rafts have been shown to be involved in Aβ
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mechanisms by which amyloid oligomers interact with neuronal
plasma membrane and trigger a neurotoxic response. It has been
reported that the neurotoxicity of some amyloid proteins, such as Aβ
peptides and calcitonin, is strongly reduced by the depletion of
ganglioside and/or cholesterol [14,15,24]. In addition, it has been
shown that Aβ binds to sialic acid-containing gangliosides [25,26].
The aims of the present study were i) to compare the cytotoxic
response to sCTOs of cultured hippocampal neurons to that observed
in different cell types with the aim of determining if a diverse
sensitivity exists; ii) to investigate if sCTO-induced neurotoxic re-
sponse is related to an imbalance of intracellular Ca2+; iii) to
characterize the role played by lipid rafts in sCTO toxicity.
2. Materials and methods
2.1. Preparation of sCTO and Aβ solutions
Lyophilized sCT (European Pharmacopoeia, EDQM, France) was
stored at −18 °C before use. sCTO 1 mM solution was prepared by
dissolving the protein in 5 mM phosphate buffer, pH 7.4 and
incubated at room temperature for 3 h. No stock solutions of protein
were employed. After 3 h, sCT solutions, containing sCTOs, were
diluted to a ﬁnal concentration of 80 μM for CD, TEM, neurotoxicity
and Ca2+ inﬂux experiments and 25, 60, 80 or 120 μM for growth
curves. To analyze sCT effects in its monomeric form, sCT was diluted
in deionized water (1 mM) immediately before use. Aβ oligomers
were prepared as described by Stine et al. [27]. Brieﬂy, lyophilized 1–
42 Aβ peptide, (Bachem, Switzerland), was dissolved in 1,1,1,3,3,3-
hexaﬂuoro-2-propanol (HFIP, Sigma, USA) and dried. Before use, an
aliquot was dissolved in dimethyl sulfoxide (5 mM), brought to 1 mM
in Minimum Essential Medium (MEM, Invitrogen, Italy), incubated at
4 °C for 24 h. The ﬁnal dilution was 20 μM.
2.2. Transmission electron microscopy
Negative stainingwas obtained using a phosphotungstic acid (PTA)
2% w/v solution, buffered at pH 7.3 with NaOH. To avoid salt
precipitation from PTA and/or NaOH, which can be misinterpreted
as actual structures, the staining solution was ﬁltered before each
preparation through polycarbonate 0.2 μm pore ﬁlters. A droplet of
protein solution was deposited onto 400-mesh copper grids for
electron microscopy and covered with a thin amorphous carbon ﬁlm
(about 20 nm). When the grid was dried, a droplet of PTA was
deposited and let dry. The samples were studied at a Zeiss 902
Transmission Electron Microscope, operating at 80 kV, equipped with
an Electron Energy Loss ﬁlter. In order to enhance the contrast, the
microscope was used in the Electron Spectroscopy Imaging mode
ﬁltering atΔE=0 eV. The image acquisitionwas performedby a digital
HSC2 CCD camera, 1 k for 1 k pixels, (Proscan gmbh, Germany),
thermostatted by a Peltier cooler model WKL 230 (Lauda gmbh,
Germany). Image analysis and quantiﬁcation was performed by the
digital image analyzer analySIS 3.0 (Sis gmbh,Germany). This software
allows to enhance contrast and sharpness of the acquired images and
to perform morphological quantiﬁcation and statistics. The dimen-
sional measurements were performed after a careful magniﬁcation
calibration of thewhole imaging system based on reference standards.
2.3. Circular dichroism (CD) measurements
CD measurements were performed on a Jasco J-715 spectro-
polarimeter (Jasco Corporation, Japan) in the far-UV region (260–
190 nm). All spectra, mean of 4 different scans, were blank subtracted.
Quartz cells of 0.1 cm path-length were employed. The spectral
resolution was 0.1 nm and the speed scan 50 nm/min. All CD spectra
were reported asΔε=[Θ]/3300, where [Θ] is equal to (θ×100)/(l×C)(θ is the measured ellipticity, C is the molar amino acidic concentration
(8×10−5×32 M) and l is the path-length in cm). CD spectra were
analyzed quantitatively by a ﬁtting procedure performed using the
CDSSTR software available at the website of the Birkbeck College of the
University of London.
2.4. Cell cultures
Primary hippocampal neurons were prepared from embryonic-
day-18 rat brain, according to themethod of Brewer et al. [28], slightly
modiﬁed [29]. All experimental procedures were in line with the
“Ethical principles and guidelines for scientiﬁc experiments on
animals” of the Swiss Academy of Medical Sciences and national
laws. After dissection, the hippocampi were treated with 2.5% trypsin
and dissociated. The cells were plated in 24-well plates, containing
poly-L-lysine-treated glass coverslips, in MEM, containing 10% heat-
inactivated Fetal Calf Serum (FCS). After 2 h, the cell culture medium
was substituted with Neurobasal medium with B27 supplement
(NBM/B27, Invitrogen, Italy), 700 μl for well. At Day-In-Vitro (DIV) 1,
5 μM arabinosylcytosine was added. Neuronal cell cultures contained
less than 1% of astrocytes, as shown by glial ﬁbrillary acidic protein
staining (data not shown). Hippocampal neurons were used at DIV6
(immature neurons) and 14 (mature neurons). Primary astrocytic
cultures were obtained from embryonic-day-18 rat brain cortex and
cultivated in MEM/FCS. Cultures were trypsinized and replated twice
before use. MG-63 cells (human osteosarcoma cell line), purchased
from the Istituto Zooproﬁlattico Sperimentale della Lombardia e
dell'Emilia (Brescia, Italy), were grown in monolayer in tissue culture
ﬂasks containing RPMI (Invitrogen, Italy) supplementedwith 10% FCS.
NIH-3T3 (mouse embryo ﬁbroblasts), purchased from the American
Type Culture Collection (ATCC), were grown in monolayer in tissue
culture ﬂasks containing DMEM (Invitrogen, Italy) supplemented
with 10% FCS.
2.5. Treatments
For apoptosis detection and immunolabeling, 300 μl of cell culture
medium fromeach coverslip-containingwellwas removed and kept in
the incubator (conditionedmedium). The cellswere given sCTOs or Aβ
for 20 min. The cell culturemediumwas then removedand substituted
with the conditioned medium and the cells ﬁxed after 24 h. For
evaluation of intracellular Ca2+, sCTOswere given directly to thewells
on the microscope stage, after 10 min recording. For sialic acid
depletion, mature hippocampal neurons were treated with a neur-
aminidase (NAA) cocktail, composed of 11.7 mU of Vibrio cholerae
NAA and 3.3 mU of Arthrobacter ureafaciens NAA (Sigma), in medium
for 1 h at 37 °C prior to sCTOs. For cholesterol depletion, cells were
treated with 2 mM MCDX (Sigma) for 45 min at 37 °C prior to sCTOs.
For deﬁning the role of the NMDA receptor in sCTOs-induced changes
in intracellular Ca2+, in some experiments hippocampal neuronswere
pre-treated with 2 μM thapsigargin (10 min prior to sCTOs) or 10 μM
MK801 (5 min prior to sCTOs) or one of the following antibodies,
45 min prior to sCTOs: polyclonal anti-NR1, (1:100, Upstate Biotech-
nology), polyclonal anti GM1 (1:100, Chemicon), polyclonal anti-
Bovine Serum Albumin (BSA), 100 μg/ml, kind gift of Paola Margutti.
2.6. Immunocytochemistry
Cell cultures were ﬁxed in 4% paraformaldehyde in PBS, 0.12 M in
sucrose, and permeabilized with Triton X-100 (0.2%, Sigma). Hippo-
campal neurons were immunostained for Microtubule-Associated
Protein 2 (MAP2), polyclonal antibody diluted 1:200 (Chemicon) and
synaptophysin, monoclonal antibody diluted 1:200 (Millipore). Sec-
ondary antibodies were FITC-conjugated rabbit anti-mouse and TRITC-
conjugated goat anti-rabbit IgGs (Sigma). Nuclei were counterstained
with Hoechst 33258. Samples were observed at an Eclipse 80i
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2.7. Optical ﬂuorimetric recordings
Optical ﬂuorimetric recordings with Fura-2 AM were used to eval-
uate the intracellular Ca2+ concentration. Fura-2 AM stock solutions
were obtained by adding 50 µg of Fura-2 AM to 50 µl of 75%DMSOplus
25% pluronic acid. Cells were bathed for 60 min at room temperature
with 5 µl of stock solution diluted in 1 ml of extracellular solution (in
mM: 125 NaCl, 1 KCl, 5 CaCl2, 1 MgCl2, 8 glucose, and 20 HEPES, pH
7.35) for a ﬁnal Fura-2 AM concentration of 5 µM. This solution was
then removed and replaced with extracellular solution, and the dishes
were quickly placed on themicroscope stage. Tomeasure ﬂuorescence
changes, a Hamamatsu (Shizouka, Japan) Argus 50 computerized
analysis system was used, recording every 6 s the ratio between the
values of light intensity at 340 and 380 nm stimulation.
2.8. Apoptosis detection
To detect apoptosis, cells were ﬁxed as described, stained with
Hoechst 33258 and observed at the Nikon ﬂuorescence microscope.
Non-apoptotic cells exhibit a diffuse nuclear ﬂuorescence while apo-
ptotic nuclei appear fragmented or highly condensed. In some
experiments, neurons were treated with the TUNEL technique, using
the DeadEnd kit (Promega, Madison, WI) and observed at a Nikon
Optiphotmicroscope. Differential counts of normal and apoptotic cells
were performed on randomly chosen microscopic ﬁelds for a total of
at least 200 cells for each coverslip. Two coverslips were scored for
each condition. The values obtained for each coverslip were averaged
to produce a single mean value for each experiment.
2.9. Growth curves
In order to determine cell proliferation, MG-63 and NIH-3T3 cells
were seeded at 2×104 cells/ml of cell culture medium and incubated
at 37 °C in a 5% CO2 atmosphere. After 24 h of incubation, cells were
treated with 25, 60, 80 or 120 μM sCTO for 20 min and then left to
grow in the medium in absence of sCTO for 24, 48 and 72 h. Untreated
MG-63 cells were considered as control. After each time of incubation,
cells were detached by ﬁrst adding 10 mM EDTA (pH 7.4) and, once
this solution was removed, by adding 0.25% trypsin and counted by
using a Neubauer chamber. Each point was conducted in triplicate.
2.10. Preparation of low-density Triton-insoluble (LDTI) plasma
membrane domains
The different cell types were fractionated using a detergent (1%
Triton X-100, Sigma)-containing method [30]. The cells were washed
in ice cold PBS twice and lysed in 750 μl MES-buffered saline (MBS:
25 mMMES pH 6.5, 150 mMNaCl), containing 1% Triton X-100, 1 mM
Na3VO4 and protease inhibitor cocktail (Roche, Indianapolis, IN) for
30 min on ice. Cell lysate was Dounce homogenized, adjusted to 40%
sucrose and placed at the bottom of an ultracentrifuge tube. A 5–30%
linear sucrose gradientwas thenplaced above the homogenate and the
mixture was centrifuged at 45,000 rpm for 16 h at 4 °C in an SW60
rotor (Beckman Instruments, Palo Alto, CA). Lipid raft fractions are
visible as a light-scattering band migrating at approximately 20%
sucrose. Twelve 0.375 ml fractions were collected from the top to the
bottom of the gradient. The lipid rafts were separated from other
fractions, diluted in MBS and centrifuged at 30,000 ×g for 30 min at
4 °C. Protein content of totalmembrane and lipid raftswas determined
by BCA assay (Pierce Rockford, Ill) using bovine serum albumin as a
standard.2.11. Lipid extraction and thin-layer chromatography
Total lipids were extracted according to the method of Folch et al.
[31]. Total membranes (50 μg) and lipid rafts (1.5 μg) were diluted
with equal volume of deionizedwater. Total lipids were dissolved into
chloroform/methanol (2:1 v/v) and applied to TLC plates. The spot
corresponding to cholesterol was ﬁrst identiﬁed by co-migration with
the cholesterol standard. Cholesterol was separated by TLC using
acetic acid: hexane: ether ethyl (1:70:30 v/v/v) as the developing
solvent andwas visualized by copper acid (3%w/v) staining. The plate
was heated for a few minutes at 180 °C. The quantity of cholesterol
was determined by densitometry and comparison with 20 µg of
standard compound using the imaging densitometer GS -700 (Bio-
Rad).
2.12. Statistical analysis
All data were represented as mean±SEM and analyzed by one-
way ANOVA followed by Bonferroni's Multiple Comparison (Figs. 4
and 5) or by unpaired t-test analysis (Fig. 3) using the Prism program
(GraphPad). pb0.05 was considered signiﬁcant.
3. Results
3.1. sCT forms amyloid-like oligomers
We ﬁrst proceeded to obtain and characterize samples of sCT in an
early stage of the aggregation process. For this purpose, sCT (1 mM)
was dissolved in phosphate buffer (5 mM) and allowed to aggregate
for 3 h at room temperature, to facilitate the aggregation process. To
obtain sCT monomers, sCT was dissolved in pure deionized distilled
water, immediately before use, as previously suggested [14–16]. As
demonstrated by Energy Filtered-Transmission Electron Microscopy
(EF-TEM) analysis, aggregated sCT (Fig. 1A) formed small isolated
globules of mean diameter of about 14 nm (Fig. 1C). These features
represent the classical intermediates occurring between monomers
and mature ﬁbrils and show a remarkable similarity with Aβ olig-
omers and other amyloid proteins [19,20]. No mature ﬁbrils were
observed. When sCT was dissolved in distilled water and observed
without pre-incubation (Fig. 1B), only very small white dots, of mean
diameter of about 5 nm (Fig. 1C), were present, likely representing
sCT monomers or small molecular weight oligomers, in analogy to
what observed for bovine [14,15] and human [16] CT. CD data
(Fig. 1D), processed according to Whitmore and Wallace [32],
indicated that, in sCT freshly dissolved in distilled water, the random
coil component was 72% while the β-structure was 23% (5% of α-
structures). It is well known that sCT in water solution and in mono-
meric state is mainly random coil [33]. CD data from sCT dissolved in
phosphate buffer and aggregated for 3 h (Fig. 1D), show that, in this
very early aggregation stage, the amount of β-structure rose to about
28% while the amount of random coil fell to 67%. The amount of α-
structures did not change. This is consistent with the aggregation
process described for the amyloid proteins, where random compo-
nents tend to organize in β-structures. This result is in good agree-
ment with similar experiments [11,16].
3.2. sCTOs damage ﬁne neurites and synapses like Aβ oligomers
Neuritic damage is a well-described effect of Aβ in hippocampal
neurons in culture. Furthermore, synaptic damage, a hallmark of AD,
has been put in relation to the presence of Aβ oligomers [34]. Since
sCTOs have morphological and structural similarities to amyloid
proteins, we asked if the effects induced by sCTOs on neurites and
synapses in mature hippocampal neurons were similar to those
induced by Aβ oligomers. We immunostained mature neurons for
MAP2, a component of the dendritic cytoskeleton, to label the neuritic
Fig. 1. sCT forms typical amyloid aggregates in PBS. EF-TEM revealed that 1 mM sCT formed small gobular oligomers after 3 h of incubation in phosphate buffer at room temperature
(A), of a mean diameter of about 14 nm (C). Mature ﬁbrils were not present. sCT dissolved in distilled water (B) and analyzed without incubation showed that only very small white
dots could be observed, likely representing monomers or small molecular weight oligomers, of mean diameter of about 5 nm (C). D: The CD spectra are reported in D. sCTO (dotted
line) gave 67% of random coil, 28% of β-structure and 5% of α-structure, while sCT monomers (continuous line) gave 72% for the random component, 23% for the β-structure and 5%
of α-structure. Bar=50 nm.
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label synapses. When compared to control cultures, both sCTOs and
Aβ oligomers induced a remarkable dendritic loss, especially in the
ﬁnest branches (Fig. 2, upper panel). In addition both of them caused
an evident decrease in the number of synaptic boutons (Fig. 2, lower
panel).
3.3. sCTOs are cytotoxic for mature hippocampal neurons, but not for
other cell types
Amyloid oligomers are thought to initiate an apoptotic cascade,
leading to neuronal cell death [35,36]. To verify if sCTOs had a pro-
apoptotic effect, to more closely link cytotoxicity to Ca2+ imbalance,
we applied a protocol reminiscent of the “delayed treatment
paradigm”, described by Choi in 1988 [37], where a brief (20 min)
excitotoxic insult is followed by 24-h-recovery in cell culturemedium.
The overstimulation of N-methyl-D-aspartate (NMDA) receptor
obtained with this treatment induces an intense increase in intracel-
lular Ca2+ that preferentially triggers an apoptotic pathway of cell
death. Similarly, we exposed the cell cultures to 20-min treatment
with sCTOs and allowed a 24-h-recovery in cell culture medium in
absence of sCTOs. We estimated the apoptotic rate by identifyingnuclei showing fragmentation or condensation of chromatin, using the
Hoechst stain. Mature hippocampal neurons, at DIV14, showed a
marked increase of the apoptotic rate, when treated with sCTOs, with
respect to controls (Fig. 3A,B). The results were conﬁrmed by the
Terminal transferase-mediated dUTP-biotin Nick End-Labeling TUNEL
assay (Fig. 3B,C). We then analyzed sCTOs cytotoxicity in immature
hippocampal neurons (6 DIV) and non-neuronal primary cultures
(cortical astrocytes from rat embryos) or immortalized cell lines of
non-neural histogenesis (MG63 osteoblasts and NIH-3T3 ﬁbroblasts).
None of them showedmodiﬁcations of the apoptotic rate, as shown by
theHoechst stain. Growth curves ofMG63osteoblasts (Fig. 4) andNIH-
3T3 ﬁbroblasts (data not shown) were also unaffected. It should be
noted that apoptosis in mature hippocampal neurons was related to
the presence of oligomeric structures, since when CT was dissolved in
water and usedwithout previous incubation, no signiﬁcant increase in
cell death was observed (Fig. 5A), as already indicated [13,14].
3.4. sCTOs increase intracellular Ca2+ in mature hippocampal neurons,
but not in other cell types
A number of ﬁndings support the hypothesis that amyloid proteins
form Ca2+-permeable channels on cell membranes, which induce a
Fig. 2. sCTOs and Aβ oligomers similarly damage the neuritic tree and synapses in mature hippocampal neurons. Mature hippocampal neurons were treated with 80 μM sCTOs or
20 μMAβ for 20 min, washed, fed with conditioned medium and kept in culture for 24 h. After ﬁxation, cells were immunostained for MAP2 (red) and synaptophysin (green). Nuclei
were counterstained with Hoechst 33258 (blue). In control cultures, anti-MAP2 antibody evidences a rich dendritic tree (upper panel, bar=50 μm), while synapses appear as green
dots along the dendrite (lower panel, bar=10 μm). After sCTO or Aβ treatments, the extension of the dendritic treewas evidently reduced (upper panel) and the number of synapses
decreased (lower panel).
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monitored intracytoplasmic freeCa2+byFura 2AM, after administration
of sCTOs, in mature and immature hippocampal neurons, primary
cortical astrocytes, MG63 osteoblasts and NIH-3T3 ﬁbroblasts (Fig. 3D,
E). While mature hippocampal neurons had an intense and sustained
increase in cytosolic Ca2+, which involved all the recorded cells without
recovery for the duration of the experiments (8 min) (Fig. 3D,E),
immature hippocampal neurons, astrocytes andNIH-3T3ﬁbroblasts did
not show any change in intracellular Ca2+.MG63osteoblasts did show a
perturbation in cytosolic Ca2+, but it consisted in a much lower and
rapidly recovering increase, which affected only a minority of cells. As
for increased apoptosis, Ca2+ perturbation in mature hippocampal
neurons was related to the presence of oligomers, since treatment with
CTmonomers did not induce any change in intracellular Ca2+ (Fig. 5B).
Thus the pro-apoptotic effect of sCTOs in hippocampal neurons was
conceivably related to the intense and unbalanced Ca2+ increase, which
was lacking in the other cell types.3.5. Lipid rafts are more abundant in mature hippocampal neurons than
in the other cell types
Wehave recently shown that the presence of GM1- and cholesterol-
enriched lipid rafts favors the formation of Ca2+-permeable, sCTO ion-
channels in model membranes [18]. To quantitatively investigate
differences in the lipid composition of the different cell types, we
evaluated the ratio between cholesterol in low-density Triton-insoluble
(LDTI) plasmamembrane domain and total cholesterol (weight %), as aFig. 3. sCTO induces increase in apoptosis and intracellular Ca2+ levels in mature hippocam
ﬁbroblasts andMG3 osteoblasts were treated with sCTO for 20 min, fed with conditioned me
33258 and apoptotic nuclei counted. Apoptotic nuclei are expressed as percentage of tota
signiﬁcant increase in the apoptotic rate was evident only for mature neurons while all other
B: Details of apoptotic nuclei stained with Hoechst (arrowheads) and TUNEL. C: After trea
treated for the TUNEL assay. Positive nuclei were counted and percentage of apoptotic nuclei
conﬁrmed that apoptosis more than doubled in sCTO-treated mature hippocampal neurons
ﬂuorimetric recordings with Fura-2 AM in the different cell cultures. Fura-2 AM-loaded c
corresponds to one cell. In mature hippocampal neurons only, sCTOs induced a rapid and int
(−60 s) and after the application of sCTOs (480 s), for each different cell culture. Bars repres
experiment. A signiﬁcant increase in intracellular Ca2+ was observed after treatment withmeasure of lipid raft content in the plasma cell membrane. Results
clearly indicate that mature neurons show the highest content in lipid
rafts (Fig. 6A), with respect to the other cell types.3.6. Is sCTO-induced Ca2+ rise due to preexisting ion channel
stimulation?
Some authors sustain that amyloid oligomers insert into the
neuronalmembrane to form a cation-conducting pore, leading to Ca2+
dysregulation, and favor the hypothesis that stimulation of preexisting
Ca2+-permeable ion channels is not involved [5,39]. Other authors
have, in contrast, evidenced a role for glutamate receptor activation in
the neurotoxic effect of amyloid proteins, such as Aβ [40–42] and
HypF-N [43]. To explore the role of glutamate receptors in sCTO
neurotoxicity, we ﬁrst tried to establish if the observed Ca2+ increase
in mature hippocampal neurons after sCTO treatment was due to an
intracellular release or to an extracellular inﬂux. To this aim, we used
thapsigargin, a speciﬁc sarcoplasmic/endoplasmic reticulum calcium
ATPase pump inhibitor, which depletes intracellular Ca2+ stores. Two
μM thapsigargin evoked only a very inconspicuous rise in intracellular
Ca2+, consistent with Ca2+leakage from intracellular stores, but
subsequent application of sCTOs oligomers produced a large and
rapid increase, similar to that observed in control cells without
thapsigargin, suggesting that sCTO-induced Ca2+ rise was mostly due
to an extracellular inﬂux (Fig. 7A). Then we moved to analyze if the
NMDA receptor (which is the glutamate receptor mostly responsible
for excitotoxic Ca2+ rise in neurons) was involved in the inﬂux. First,pal neurons. A: Mature and immature hippocampal neurons, primary astrocytes, 3T3
dium and kept in culture for further 24 h. After ﬁxation, cells were stained with Hoechst
l nuclei. Bars represent the mean±S.E.M. of at least six independent experiments. A
cell types did not show any difference in cell death, compared to their control cultures.
tment with sCTOs, as already described, mature hippocampal neurons were ﬁxed and
is expressed as mean±S.E.M. from four different experiments in duplicate. TUNEL assay
. D: Representative experiments of the effects of sCTOs on intracellular Ca2+ by optical
ells were recorded during baseline and after application of sCTOs (arrows). Each line
ense elevation of intracellular Ca2+. E: Intracellular Ca2+ values were compared before
ent mean values±S.E.M of Ca2+levels of Figure D. At least 7 cells were evaluated in each
sCTOs only in mature hippocampal neurons. Bars=50 μm. *=pb0.05 vs control.
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inhibitor. MK801 poorly affected sCTO-driven Ca2+ inﬂux (Fig. 7B),
causing only a small delay in the response, while it completely blocked
NMDA-driven Ca2+ increase (data not shown). sCTOs, however, could
interact with the NMDA receptor at a site different from that bound toMK801, thus modifying receptor structure and regulation. To this
purpose,we pre-treated hippocampal neuronswith antibodies against
the NR1subunit, which is a mandatory component of all NMDA
receptors, to check if immunoglobulins speciﬁcally bound to the
receptor could hinder its interaction with sCTOs and suppress Ca2+
Fig. 4. sCTO does not inﬂuence cell proliferation. MG-63 osteoblasts were treated with
25, 60, 80 or 120 μM sCTO for 20 min and then let to grow in the medium in absence of
sCTO for 24, 48 and 72 h. Cells were then detached and counted. Results are represented
as mean±S.E.M. of three different experiments. No modiﬁcations of cell growth were
found in treated cells with respect to control.
Fig. 5. sCTO neurotoxicity is related to the presence of oligomers. A: Mature
hippocampal neurons were treated sCTOs or sCT freshly dissolved in water (sCT
monomers), as already described. After ﬁxation, cells were stained with Hoechst and
apoptotic nuclei counted. Apoptotic nuclei are expressed as percentage of total nuclei.
Bars represent the mean±S.E.M. of at least six independent experiments. sCT dissolved
in water did not induce a signiﬁcant increase in apoptosis. B: Representative
experiments of the effects of treatment with sCT monomers or sCTOs on intracellular
Ca2+ by optical ﬂuorimetric recordings with Fura-2 AM in mature hippocampal
neurons. Fura-2 AM-loaded cells were recorded during baseline and after application of
sCT monomers (ﬁrst arrow) and sCTOs (second arrow). Each line corresponds to one
cell. A rapid and intense elevation of intracellular Ca2+ was obtained after sCTOs, but
not after sCT monomers. *=pb0.05.
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slightly delayed; however, after a few seconds, it reached the same
intensity and stability as in absence of the antibody (Fig. 7C). To further
analyze sCTO response, we pre-treated mature hippocampal neurons
with an antibody-anti GM1, in the attempt to block the pore forma-
tion. The presence of the antibody completely abolished sCTOs-
induced Ca2+ increase. After 10 min, an administration of 100 μM
NMDA induced a classical abrupt and intense Ca2+ rise, supporting the
fact that the NMDA receptor activity had not been modiﬁed by the
presence of anti-GM1 antibody (Fig. 7D). The response was reliably
due to a speciﬁc interaction with GM1, since unrelated antibodies,
such as anti-BSA, at the same concentration, did not affect sCTO
response (Fig. 7E). These results suggest that althoughNMDA receptor
may be rapidly activated at the beginning of the response, the
formation of sCTO Ca2+-permeable pores is the main mechanism
responsible for Ca2+ dysregulation.
3.7. Depletion of gangliosides affects sCTO response in mature
hippocampal neurons
To further support the hypothesis that the highest content in lipid
rafts in mature hippocampal neurons was related to their suscepti-
bility to the sCTO pro-apoptotic effect, we tested if lipid raft depletion
modiﬁed sCTO-induced cytotoxicity and Ca2+ inﬂux. In mature hip-
pocampal neurons treated with neuraminidase (NAA), which specif-
ically removes gangliosides, a characteristic component of lipid rafts,
sCTO-driven increase in the apoptotic rate was remarkable reduced
(Fig. 8A); in parallel, cytosolic Ca2+ increase was inhibited (Fig. 8B).
This observation strongly supports the hypothesis that the high
content in lipid rafts promotes sCTO neurotoxicity. In addition, we
also pre-treated the cells with MCDX, in order to remove cholesterol
from the plasma membrane. Again, we observed a signiﬁcant re-
duction in the apoptotic rate of hippocampal neurons, although they
showed a variable response to sCTOs in terms of Ca2+ inﬂux. The
majority of treated cells rapidly reverted to the initial Ca2+ level
(Fig. 8B).
4. Discussion
Pathologies deriving from misfolded amyloid proteins are partic-
ularly frequent in CNS. The reasons for this peculiar vulnerability are
presently unknown, but several hypotheses may be formulated. The
brain may provide a particularly suitable environment for proteinmisfolding process, or, alternatively, neuronal cellsmay be particularly
sensitive to the toxic potential of amyloid proteins. We used CT, a
protein that undergoes a process of amyloid aggregation, to investigate
if neuronal cells are more vulnerable to amyloid proteins than cells of
different histogenesis, a comparative study that to our knowledge has
never been performed.We chose sCT because it is known to aggregate
more slowly than human CT [11,16]. To observe the early stages of
oligomerization, incubation was limited to 3 h to obtain a sample rich
in oligomers, but devoid of ﬁbrils.
Consistently with its amyloid nature, in mature (14 DIV) hippocam-
pal neurons, sCTOs induced cell damage that resembled remarkably that
induced by Aβ, such as altered neuritic tree, with loss of the ﬁnest
branches, and synaptotoxicity, evidenced by loss or alteration of
synaptic structures. This is of particular relevance since damage of
synapses is considered to be responsible for neuronal dysfunction
underlying AD cognitive impairment and represents the pathologic
ﬁnding that best correlateswith the degree of dementia [4]. To highlight
speciﬁc susceptibility of neuronal cells to amyloid toxicity,we compared
Fig. 7. Stimulation of NMDA receptors does not play an important role in sCTO-driven
Ca2+ inﬂux. Changes in intracellular Ca2+ were evaluated by optical ﬂuorimetric
recordings with Fura-2 AM in mature hippocampal neurons. Each line corresponds to
one cell. To establish if sCTO-induced Ca2+ increase inmature hippocampal neuronswas
due to an intracellular release or to an extracellular inﬂux, possibly mediated by
glutamate receptors, mature hippocampal neurons were treated with 2 μM thapsigar-
gin, which depletes intracellular Ca2+ stores. Thapsigargin evoked an extremely small
rise in intracellular Ca2+, consistent with Ca2+leakage from intracellular stores, while
sCTOs, administered after a few minutes, produced a much more rapid and intense
increase, similar to that observed in control cells, suggesting that sCTO-induced Ca2+
rise was mostly due to an extracellular Ca2+ inﬂux (panel A). To analyze if the NMDA
receptor (which is the glutamate receptormostly responsible for excitotoxic Ca2+ rise in
neurons) was involved in the inﬂux, we pre-treated hippocampal neurons with MK801,
a speciﬁc NMDA inhibitor. MK801 did not affect sCTO-driven Ca2+ inﬂux (panel B),
while it blocked NMDA-driven Ca2+ increase (data not shown). To rule out the
hypothesis that sCTOs could bind to the NMDA receptor at a site different from that
blocked by MK801, we pre-treated hippocampal neurons with antibodies against the
NR1subunit, to mask possible sites of interaction between sCTOs and the receptor. Even
in the presence of anti-NR1, after a slight delay, the response to sCTOs reached the same
intensity and stability as in absence of the antibody (panel C). On the contrary, pre-
treatmentwith an antibody-anti GM1, aimed at blocking the pore formation, did abolish
sCTOs-induced Ca2+ increase. After 10 min, an administration of 100 μMNMDA induced
a classical abrupt and intense Ca2+ rise, supporting the fact that the NMDA receptor
activity had not been modiﬁed by the presence of anti-GM1 antibody (panel D). Pre-
treatment with anti-BSA IgGs, an unrelated antibody, did not affect sCTO response
(panel E).
Fig. 6. Mature neurons have the highest content in lipid rafts. To quantitatively
investigate differences in the content in lipid rafts of the various cell types used in our
experiments, we evaluated the weight ratio between LDTI and total cholesterol. Results
indicate that the plasma membrane of mature hippocampal neurons showed a much
higher content in lipid rafts than immature neurons and the other cell types.
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that of two immortalized cell lines (MG63 osteoblasts and NIH-3T3
ﬁbroblasts). In addition, we also analyzed the effects on primary
astrocytic cultures from rat fetal brain, to exclude that immortalized
lines could present a more resistant phenotype, due to their manipu-
lated genome. Our results show that mature, but not immature,
hippocampal neurons respond to sCTOs with an evident increase in
apoptosis, while the other cell types did not show any increase in
cytotoxicity. Furthermore, sCTO administration to mature, but not
immature hippocampal neurons induced an intense and sustained rise
in intracellular Ca2+, while the other cell types were nearly unrespon-
sive. MG63 osteoblasts did show a slight response in terms of Ca2+ rise,
but the increase was much lower than the one observed in neurons,
rapidly disappeared and affected a very small proportion of cells.
When considering the pathogenesis of amyloid protein neurotox-
icity, two main possibilities are presently considered: i) oligomers of
small molecular weight insert into membrane bilayers to create
cytotoxic pores in a relatively non-speciﬁc mechanism [5,7–9,39]; ii)
oligomers bind to particular membrane targets as highly speciﬁc
ligands [34]. In favor of the ﬁrst hypothesis is the observation that
several disease-related amyloid proteins share a commonmechanism
for oligomer-mediated toxicity, notwithstanding their different
primary sequence [5,39]. According to this theory, the toxicity of
amyloid oligomers is intrinsically related to their aggregation state
and point to the formation of pores, with consequent dysregulation of
intracellular Ca2+, as a primary pathogenetic mechanism.
In our experiments, we found that mature hippocampal neurons
were more susceptible to sCTO-induced Ca2+ dysregulation, at
difference with the other examined cell types. Which characteristic
may be at the basis of this peculiar reactivity? A large body of evidence
sustains a role for lipid rafts in amyloid-induced neurotoxicity. Lipid
rafts have been put in relation to Aβ formation [22,23]. Of particular
interest is their involvement in the mechanisms by which amyloid
oligomers interact with neuronal plasma membrane and triggers a
neurotoxic response. It has been reported that the neurotoxicity of
some amyloid proteins, such as Aβ peptides and calcitonin, is strongly
reduced by the depletion of ganglioside and/or cholesterol [15,24]. In
addition, it has been shown that Aβ binds to sialic acid-containing
gangliosides [25,26,44]. The neuronal plasma membrane is particu-
larly rich in lipid rafts. Thus, content in lipid rafts higher than the other
cell types could render neurons more vulnerable to amyloid toxicity.
This hypothesis was conﬁrmed by our results, wheremature neuronalcells showed a much more elevated content in lipid rafts of the other
cells types examined. It has also been demonstrated that lipid rafts
increase in the plasma membrane during in vitro maturation in
hippocampal neurons [45]. This could explain why mature neurons
were sensitive to sCTO toxicity, but immature neurons were not. In
agreement with this hypothesis, we found that a much higher content
in lipid rafts was present in the plasma membrane of 14 DIV
hippocampal neurons, with respect to 6 DIV neurons, primary
astrocytic cell cultures, MG63 osteoblasts and NIH-3T3 ﬁbroblasts.
We have recently shown that the presence of GM1- and cholesterol-
enriched lipid rafts favors the formation of Ca2+-permeable, sCTO ion-
Fig. 8. Lipid raft depletion in the neuronal plasma membrane affects sCTO-induced
neurotoxicity and Ca2+ perturbation. A: Mature hippocampal neurons were given
sCTOs as already described, with or without pre-treatment with MCDX or NAA (the
effect or MCDX or NAA alone is also shown). Apoptotic nuclei are expressed as
percentage of total nuclei. Bars represent the mean±S.E.M. of at least six independent
experiments. B: Representative experiments of the effects of MCDX or NAA pre-
treatment on intracellular Ca2+ perturbation induced by sCTOs. Fura-2 AM-loaded cells
were recorded during baseline and after application of sCTOs in control cultures or
cultures pre-treated with MCDX or NAA. Each line corresponds to one cell. Intracellular
Ca2+ showed an initial and mostly transitory rise in cells treated with MCDX, while it
was completely unaffected by sCTOs in all cells pre-treated with NAA. *=pb0.05.
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facilitate the formation of sCTO Ca2+-permeable pores in mature
hippocampal neurons, a mechanism hypothesized for other amyloid
proteins [39] that implies a non-speciﬁc interaction, independent from
the stimulation preexisting Ca2+-permeable plasma membrane ion
channels. This view has, however, been challenged by authors who
evidenced a role for glutamate receptors in Aβ [40–42] and HypF-N, the
N-terminal domain of the Escherichia coli hydrogenase maturation
factor, a protein that is not associated with any amyloid disease butshows an aggregative behavior [43]. It has been hypothesized at this
regard that oligomersmay act at two steps, separated in time [43]. Aﬁrst
step, very rapid (in the order of seconds) where Ca2+ increases
following glutamate receptor stimulation by the oligomers, followed by
a second, delayed step where oligomers permeabilize nonspeciﬁcally
the cellmembrane, possibly via the formation of pores. Our results show
that sCTO-induced Ca2+ entry was poorly affected by the presence of
MK801, an NMDA receptor blocker, or pre-treatment with an anti-NR1
antibody, used tomask possible sites of interactions between sCTOs and
the NMDA receptor, the responses in these cases being only slightly
delayed. On the contrary, pre-treatment of neurons with an antibody
against GM1 completely suppressed sCTO-driven Ca2+ rise, without
altering NMDA receptor activity. On the basis of the delayed Ca2+ rise
observed when NMDA receptor was blocked, we cannot exclude that a
component due to an interaction between sCTOs and the NMDA
receptor is present, or that theAMPA type of glutamate receptors,which
have not been examined in the present study, may be involved.
However, the block of Ca2+ response obtained with anti-GM1
antibodies strongly supports the conclusion that the intense and
protracted Ca2+ dysregulation observed after sCTOs treatment is
reliably due to the pore formation. As further support to the role of
lipid rafts in sCTO toxicity, we observed that lipid raft disruption
obtained by NAA, which removes sialic acid from gangliosides, a
characteristic component of lipid rafts, inhibited Ca2+ rise andprotected
against sCTO neurotoxicity, probably modifying the plasma membrane
area susceptible to the formation of the pore-like structures. This
perspective is, in our opinion, pretty innovative, since it does not focus
on the inhibition of the amyloid oligomer formation but to the
hindrance of its interaction with the neuronal cell membrane. MCDX,
which removes cholesterol, also reduced both sCTO toxicity and Ca2+
rise, but with a less clear-cut effect than NAA. Actually, the role of
cholesterol in amyloid toxicity is quite controversial. A comparative
studyon the susceptibility of different cell lines to toxicityof the amyloid
protein HypF-N showed inverse relation to membrane content in total
cholesterol [46]. On the other hand, it has recently been demonstrated
that membrane cholesterol levels in mature neuron are signiﬁcantly
higher than those detected in young ones and that decreasing
membrane cholesterol in mature neurons reduces their susceptibility
to Aβ-induced cell death [47].
The present ﬁndings show that our previous results on the
mechanism of Ca2+-permeabilization induced by sCTOs in model
membranes also applies to plasma membrane of living cells, and that
sCTOsbehaves asapathologic amyloidprotein inducingapro-apoptotic,
neurotoxic effect. This response is likely caused by intracellular Ca2+
dysregulation, accompanied by neuritic and synaptic changes similar to
those observed after in vitro Aβ treatment and linked to a particular
membrane lipid composition: the coexistence of gangliosides and
cholesterol, characteristic of lipid rafts. In conclusion, we suggest that
the high content in lipid rafts of mature neuronal plasma membrane
mayunderlie a particular susceptibility to the cytotoxic effect of amyloid
protein. This characteristic may contribute to the speciﬁc vulnerability
of CNS to misfolded protein diseases and could be the object of further
studies aimed at deﬁning new targets for innovative therapeutic
strategies.
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